Pharmacological gating modulation of small- and intermediate-conductance Ca²⁺-activated K⁺ channels (K_Ca2.x and K_Ca3.1)

References

• Balut CM, Hamilton KL, Devor DC. Trafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca2+-activated K+ channels: a novel target for medicinal chemistry efforts? Chem Med Chem 2012; 7:1741-55; PMID:22887933; http://dx.doi.org/10.1002/cmdc.201200226
   PubMed Web of Science ®Google Scholar
• Changeux JP. The concept of allosteric modulation: an overview. Drug Discov Today Technol 2013; 10:e223-8; PMID:24050272; http://dx.doi.org/10.1016/j.ddtec.2012.07.007
   PubMedGoogle Scholar
• Sieghart W. Pharmacology of benzodiazepine receptors: an update. J Psychiatry Neurosci 1994; 19:24-9; PMID:8148363
   PubMed Web of Science ®Google Scholar
• Wang RX, Jiang WP. Changes of action potential and L-type calcium channel current of Sprague-Dawley rat ventricular myocytes by different amlodipine isomers. Can J Physiol Pharmacol 2008; 86:620-5; PMID:18758511; http://dx.doi.org/10.1139/Y08-065
   PubMed Web of Science ®Google Scholar
• Greenberg DA, Cooper EC, Carpenter CL. Calcium channel ‘agonist’ BAY K 8644 inhibits calcium antagonist binding to brain and PC12 cell membranes. Brain Res 1984; 305:365-8; PMID:6204725; http://dx.doi.org/10.1016/0006-8993(84)90444-X
   PubMed Web of Science ®Google Scholar
• Schramm M, Thomas G, Towart R, Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca2+ channels. Nature 1983; 303:535-7; PMID:6190088; http://dx.doi.org/10.1038/303535a0
   PubMed Web of Science ®Google Scholar
• Wei AD, Gutman GA, Aldrich R, Chandy KG, Grissmer S, Wulff H. International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev 2005; 57:463-72; PMID:16382103; http://dx.doi.org/10.1124/pr.57.4.9
   PubMed Web of Science ®Google Scholar
• Adelman JP, Maylie J, Sah P. Small-conductance Ca2+-activated K+ channels: form and function. Annu Rev Physiol 2012; 74:245-69; PMID:21942705; http://dx.doi.org/10.1146/annurev-physiol-020911-153336
   PubMed Web of Science ®Google Scholar
• Wulff H, Castle NA. Therapeutic potential of KCa3.1 blockers: recent advances and promising trends. Expert Rev Clin Pharmacol 2010; 3:385-96; PMID:22111618; http://dx.doi.org/10.1586/ecp.10.11
   PubMedGoogle Scholar
• King B, Rizwan AP, Asmara H, Heath NC, Engbers JD, Dykstra S, et al. IKCa channels are a critical determinant of the slow AHP in CA1 pyramidal neurons. Cell Rep 2015; 11:175-82; PMID:25865881; http://dx.doi.org/10.1016/j.celrep.2015.03.026
   PubMed Web of Science ®Google Scholar
• Adelman JP. SK channels and calmodulin. Channels (Austin) 2015:1-6; PMID:25942650; http://dx.doi.org/10.1080/19336950.2015.1029688
   PubMedGoogle Scholar
• Schumacher MA, Rivard AF, Bachinger HP, Adelman JP. Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin. Nature 2001; 410:1120-4; PMID:11323678; http://dx.doi.org/10.1038/35074145
   PubMed Web of Science ®Google Scholar
• Joiner WJ, Khanna R, Schlichter LC, Kaczmarek LK. Calmodulin regulates assembly and trafficking of SK4/IK1 Ca2+-activated K+ channels. J Biol Chem 2001; 276:37980-5; PMID:11495911
   PubMed Web of Science ®Google Scholar
• Xia XM, Fakler B, Rivard A, Wayman G, Johnson-Pais T, Keen JE, Ishii T, Hirschberg B, Bond CT, Lutsenko S, et al. Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature 1998; 395:503-7; PMID:9774106; http://dx.doi.org/10.1038/26758
   PubMed Web of Science ®Google Scholar
• Fanger CM, Ghanshani S, Logsdon NJ, Rauer H, Kalman K, Zhou J, Beckingham K, Chandy KG, Cahalan MD, Aiyar J. Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. J Biol Chem 1999; 274:5746-54; PMID:10026195; http://dx.doi.org/10.1074/jbc.274.9.5746
   PubMed Web of Science ®Google Scholar
• Hougaard C, Eriksen BL, Jorgensen S, Johansen TH, Dyhring T, Madsen LS, Strøbaek D, Christophersen P. Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca2+-activated K+ channels. Br J Pharmacol 2007; 151:655-65; PMID:17486140; http://dx.doi.org/10.1038/sj.bjp.0707281
   PubMed Web of Science ®Google Scholar
• Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, Maylie J. A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA 1997; 94:11651-6; PMID:9326665; http://dx.doi.org/10.1073/pnas.94.21.11651
   PubMed Web of Science ®Google Scholar
• Srivastava S, Li Z, Ko K, Choudhury P, Albaqumi M, Johnson AK, Yan Y, Backer JM, Unutmaz D, Coetzee WA, et al. Histidine phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate kinase B is required for activation of KCa3.1 and CD4 T cells. Mol Cell 2006; 24:665-75; PMID:17157250; http://dx.doi.org/10.1016/j.molcel.2006.11.012
   PubMed Web of Science ®Google Scholar
• Stocker M, Krause M, Pedarzani P. An apamin-sensitive Ca2+-activated K+ current in hippocampal pyramidal neurons. Proc Natl Acad Sci USA 1999; 96:4662-7; PMID:10200319; http://dx.doi.org/10.1073/pnas.96.8.4662
   PubMed Web of Science ®Google Scholar
• Wolfart J, Roeper J. Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons. J Neurosci 2002; 22:3404-13; PMID:11978817
   PubMed Web of Science ®Google Scholar
• Womack MD, Khodakhah K. Somatic and dendritic small-conductance calcium-activated potassium channels regulate the output of cerebellar Purkinje neurons. J Neurosci 2003; 23:2600-7; PMID:12684445
   PubMed Web of Science ®Google Scholar
• Ngo-Anh TJ, Bloodgood BL, Lin M, Sabatini BL, Maylie J, Adelman JP. SK channels and NMDA receptors form a Ca2+-mediated feedback loop in dendritic spines. Nat Neurosci 2005; 8:642-9; PMID:15852011; http://dx.doi.org/10.1038/nn1449
   PubMed Web of Science ®Google Scholar
• McKay BM, Oh MM, Galvez R, Burgdorf J, Kroes RA, Weiss C, Adelman JP, Moskal JR, Disterhoft JF. Increasing SK2 channel activity impairs associative learning. J Neurophysiol 2012; 108:863-70; PMID:22552186; http://dx.doi.org/10.1152/jn.00025.2012
   PubMed Web of Science ®Google Scholar
• Vick KAT, Guidi M, Stackman RW, Jr. In vivo pharmacological manipulation of small conductance Ca2+-activated K+ channels influences motor behavior, object memory and fear conditioning. Neuropharmacology 2010; 58:650-9; PMID:AMBIGUOUS; http://dx.doi.org/10.1016/j.neuropharm.2009.11.008
   PubMed Web of Science ®Google Scholar
• van der Staay FJ, Fanelli RJ, Blokland A, Schmidt BH. Behavioral effects of apamin, a selective inhibitor of the SK(Ca)-channel, in mice and rats. Neurosci Biobehav Rev 1999; 23:1087-110; PMID:10643819; http://dx.doi.org/10.1016/S0149-7634(99)00043-3
   PubMed Web of Science ®Google Scholar
• Cahalan MD, Chandy KG. The functional network of ion channels in T lymphocytes. Immunol Rev 2009; 231:59-87; PMID:19754890; http://dx.doi.org/10.1111/j.1600-065X.2009.00816.x
   PubMed Web of Science ®Google Scholar
• Feske S, Wulff H, Skolnik EY. Ion channels in innate and adaptive immunity. Annu Rev Immunol 2015; 33:291-353; PMID:25861976; http://dx.doi.org/10.1146/annurev-immunol-032414-112212
   PubMed Web of Science ®Google Scholar
• Si H, Heyken WT, Wolfle SE, Tysiac M, Schubert R, Grgic I, Vilianovich L, Giebing G, Maier T, Gross V, et al. Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res 2006; 99:537-44; PMID:16873714; http://dx.doi.org/10.1161/01.RES.0000238377.08219.0c
   PubMed Web of Science ®Google Scholar
• Brahler S, Kaistha A, Schmidt VJ, Wolfle SE, Busch C, Kaistha BP, Kacik M, Hasenau AL, Grgic I, Si H, et al. Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension. Circulation 2009; 119:2323-32; PMID:19380617; http://dx.doi.org/10.1161/CIRCULATIONAHA.108.846634
   PubMed Web of Science ®Google Scholar
• Ghanshani S, Wulff H, Miller MJ, Rohm H, Neben A, Gutman GA, Cahalan MD, Chandy KG. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 2000; 275:37137-49; PMID:10961988; http://dx.doi.org/10.1074/jbc.M003941200
   PubMed Web of Science ®Google Scholar
• Di L, Srivastava S, Zhdanova O, Ding Y, Li Z, Wulff H, Lafaille M, Skolnik EY. Inhibition of the K+ channel KCa3.1 ameliorates T cell-mediated colitis. Proc Natl Acad Sci USA 2010; 107:1541-6; PMID:20080610; http://dx.doi.org/10.1073/pnas.0910133107
   PubMed Web of Science ®Google Scholar
• Devor DC, Singh AK, Frizzell RA, Bridges RJ. Modulation of Cl- secretion by benzimidazolones. I. Direct activation of a Ca2+-dependent K+ channel. Am J Physiol 1996; 271:L775-84; PMID:8944721
   PubMed Web of Science ®Google Scholar
• Jensen BS, Strobaek D, Christophersen P, Jorgensen TD, Hansen C, Silahtaroglu A, Olesen SP, Ahring PK. Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel. Am J Physiol 1998; 275:C848-56; PMID:9730970
   PubMed Web of Science ®Google Scholar
• Pedarzani P, McCutcheon JE, Rogge G, Jensen BS, Christophersen P, Hougaard C, Strøbaek D, Stocker M. Specific enhancement of SK channel activity selectively potentiates the afterhyperpolarizing current I(AHP) and modulates the firing properties of hippocampal pyramidal neurons. J Biol Chem 2005; 280:41404-11; PMID:16239218; http://dx.doi.org/10.1074/jbc.M509610200
   PubMed Web of Science ®Google Scholar
• Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier JM, Shakkottai V. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Cur Med Chem 2007; 14:1437-57; PMID:17584055; http://dx.doi.org/10.2174/092986707780831186
   PubMed Web of Science ®Google Scholar
• Cao Y, Dreixler JC, Roizen JD, Roberts MT, Houamed KM. Modulation of recombinant small-conductance Ca2+-activated K+ channels by the muscle relaxant chlorzoxazone and structurally related compounds. J Pharmacol Exp Ther 2001; 296:683-9; PMID:11181893
   PubMed Web of Science ®Google Scholar
• Cao YJ, Dreixler JC, Couey JJ, Houamed KM. Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole. Eur J Pharmacol 2002; 449:47-54; PMID:12163105; http://dx.doi.org/10.1016/S0014-2999(02)01987-8
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan A, Raman G, Busch C, Schultz T, Zimin PI, Hoyer J, Köhler R, Wulff H. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 2009; 75:281-95; PMID:18955585; http://dx.doi.org/10.1124/mol.108.051425
   PubMed Web of Science ®Google Scholar
• Strøbaek D, Teuber L, Jørgensen TD, Ahring PK, Kjaer K, Hansen RS, Olesen SP, Christophersen P, Skaaning-Jensen B. Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime). Biochim Biophys Acta 2004; 1665:1-5; PMID:15471565; http://dx.doi.org/10.1016/j.bbamem.2004.07.006
   PubMed Web of Science ®Google Scholar
• Coleman N, Brown BM, Oliván-Viguera A, Singh V, Olmstead MM, Valero MS, Köhler R, Wulff H. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1. Mol Pharmacol 2014; 86:342-57; PMID:24958817; http://dx.doi.org/10.1124/mol.114.093286
   PubMed Web of Science ®Google Scholar
• Kasumu AW, Hougaard C, Rode F, Jacobsen TA, Sabatier JM, Eriksen BL, Strøbæk D, Liang X, Egorova P, Vorontsova D, et al. Selective positive modulator of calcium-activated potassium channels exerts beneficial effects in a mouse model of spinocerebellar ataxia type 2. Chem Biol 2012; 19:1340-53; PMID:23102227; http://dx.doi.org/10.1016/j.chembiol.2012.07.013
   PubMed Web of Science ®Google Scholar
• Hougaard C1, Hammami S, Eriksen BL, Sørensen US, Jensen ML, Strøbæk D, Christophersen P. Evidence for a common pharmacological interaction site on K(Ca)2 channels providing both selective activation and selective inhibition of the human K(Ca)2.1 subtype. Mol Pharmacol 2012; 81:210-9; PMID:22046005; http://dx.doi.org/10.1124/mol.111.074252
   PubMed Web of Science ®Google Scholar
• Hougaard C1, Jensen ML, Dale TJ, Miller DD, Davies DJ, Eriksen BL, Strøbaek D, Trezise DJ, Christophersen P. Selective activation of the SK1 subtype of human small-conductance Ca2+-activated K+ channels by 4-(2-methoxyphenylcarbamoyloxymethyl)-piperidine-1-carboxylic acid tert-butyl ester (GW542573X) is dependent on serine 293 in the S5 segment. Mol Pharmacol 2009; 76:569-78; PMID:19515965; http://dx.doi.org/10.1124/mol.109.056663
   PubMed Web of Science ®Google Scholar
• Pedarzani P, Mosbacher J, Rivard A, Cingolani LA, Oliver D, Stocker M, Adelman JP, Fakler B. Control of electrical activity in central neurons by modulating the gating of small conductance Ca2+-activated K+ channels. J Biol Chem 2001; 276:9762-9; PMID:11134030; http://dx.doi.org/10.1074/jbc.M010001200
   PubMed Web of Science ®Google Scholar
• Ji H, Hougaard C, Herrik KF, Strobaek D, Christophersen P, Shepard PD. Tuning the excitability of midbrain dopamine neurons by modulating the Ca2+ sensitivity of SK channels. Eur J Neurosci 2009; 29:1883-95; PMID:19473240; http://dx.doi.org/10.1111/j.1460-9568.2009.06735.x
   PubMed Web of Science ®Google Scholar
• Li W, Halling DB, Hall AW, Aldrich RW. EF hands at the N-lobe of calmodulin are required for both SK channel gating and stable SK-calmodulin interaction. J Gen Physiol 2009; 134:281-93; PMID:19752189; http://dx.doi.org/10.1085/jgp.200910295
   PubMed Web of Science ®Google Scholar
• Zhang M, Pascal JM, Schumann M, Armen RS, Zhang JF. Identification of the functional binding pocket for compounds targeting small-conductance Ca2+-activated potassium channels. Nat Commun 2012; 3:1021; PMID:22929778; http://dx.doi.org/10.1038/ncomms2017
   PubMed Web of Science ®Google Scholar
• Zhang M, Pascal JM, Zhang JF. Unstructured to structured transition of an intrinsically disordered protein peptide in coupling Ca2+-sensing and SK channel activation. Proc Natl Acad Sci USA 2013; 110:4828-33; PMID:23487779; http://dx.doi.org/10.1073/pnas.1220253110
   PubMed Web of Science ®Google Scholar
• Zhang M, Meng XY, Cui M, Pascal JM, Logothetis DE, Zhang JF. Selective phosphorylation modulates the PIP2 sensitivity of the CaM-SK channel complex. Nat Chem Biol 2014; 10:753-9; PMID:25108821; http://dx.doi.org/10.1038/nchembio.1592
   PubMed Web of Science ®Google Scholar
• Hopf FW, Simms JA, Chang SJ, Seif T, Bartlett SE, Bonci A. Chlorzoxazone, an SK-type potassium channel activator used in humans, reduces excessive alcohol intake in rats. Biol Psychiatry 2011; 69:618-24; PMID:21195386; http://dx.doi.org/10.1016/j.biopsych.2010.11.011
   PubMed Web of Science ®Google Scholar
• Padula AE, Griffin WC 3rd, Lopez MF, Nimitvilai S, Cannady R, McGuier NS, Chesler EJ, Miles MF, Williams RW, Randall PK, et al. KCNN genes that encode small-conductance Ca2+-activated K+ channels influence alcohol and drug addiction. Neuropsychopharmacology 2015; 40:1928-39; PMID:25662840; http://dx.doi.org/10.1038/npp.2015.42
   PubMed Web of Science ®Google Scholar
• Oliveira MS, Skinner F, Arshadmansab MF, Garcia I, Mello CF, Knaus HG, Ermolinsky BS, Otalora LF, Garrido-Sanabria ER. Altered expression and function of small-conductance (SK) Ca2+-activated K+ channels in pilocarpine-treated epileptic rats. Brain Res 2010; 1348:187-99; PMID:20553876; http://dx.doi.org/10.1016/j.brainres.2010.05.095
   PubMed Web of Science ®Google Scholar
• Schulz R, Kirschstein T, Brehme H, Porath K, Mikkat U, Kohling R. Network excitability in a model of chronic temporal lobe epilepsy critically depends on SK channel-mediated AHP currents. Neurobiol Dis 2012; 45:337-47; PMID:21889592; http://dx.doi.org/10.1016/j.nbd.2011.08.019
   PubMed Web of Science ®Google Scholar
• Alvina K, Khodakhah K. KCa channels as therapeutic targets in episodic ataxia type-2. J Neurosci 2010; 30:7249-57; PMID:20505091; http://dx.doi.org/10.1523/JNEUROSCI.6341-09.2010
   PubMed Web of Science ®Google Scholar
• Walter JT, Alvina K, Womack MD, Chevez C, Khodakhah K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci 2006; 9:389-97; PMID:16474392; http://dx.doi.org/10.1038/nn1648
   PubMed Web of Science ®Google Scholar
• Shakkottai VG, do Carmo Costa M, Dell'Orco JM, Sankaranarayanan A, Wulff H, Paulson HL. Early changes in cerebellar physiology accompany motor dysfunction in the polyglutamine disease spinocerebellar ataxia type 3. J Neurosci 2011; 31:13002-14; PMID:21900579; http://dx.doi.org/10.1523/JNEUROSCI.2789-11.2011
   PubMed Web of Science ®Google Scholar
• Cerminara NL, Rawson JA. Evidence that climbing fibers control an intrinsic spike generator in cerebellar Purkinje cells. J Neurosci 2004; 24:4510-7; PMID:15140921; http://dx.doi.org/10.1523/JNEUROSCI.4530-03.2004
   PubMed Web of Science ®Google Scholar
• McKay BE, Engbers JD, Mehaffey WH, Gordon GR, Molineux ML, Bains JS, Turner RW. Climbing fiber discharge regulates cerebellar functions by controlling the intrinsic characteristics of Purkinje cell output. J Neurophysiol 2007; 97:2590-604; PMID:17267759; http://dx.doi.org/10.1152/jn.00627.2006
   PubMed Web of Science ®Google Scholar
• Ristori G, Romano S, Visconti A, Cannoni S, Spadaro M, Frontali M, Pontieri FE, Vanacore N, Salvetti M. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial. Neurology 2010; 74:839-45; PMID:20211908; http://dx.doi.org/10.1212/WNL.0b013e3181d31e23
   PubMed Web of Science ®Google Scholar
• Feil K, Claassen J, Bardins S, Teufel J, Krafczyk S, Schneider E, Schniepp R, Jahn K, Kalla R, Strupp M. Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial. Neurology 2013; 81:1152-8; PMID:23975871; http://dx.doi.org/10.1212/WNL.0b013e3182a55f6d
   PubMed Web of Science ®Google Scholar
• Hipólito L, Fakira AK, Cabañero D, Blandón R, Carlton SM, Morón JA, Melyan Z. In vivo activation of the SK channel in the spinal cord reduces the NMDA receptor antagonist dose needed to produce antinociception in an inflammatory pain model. Pain. 2015; 156:849-58; PMID:25734988; http://dx.doi.org/10.1097/j.pain.0000000000000124
   PubMed Web of Science ®Google Scholar
• Edwards G, Feletou M, Weston AH. Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflugers Arch 2010; 459:863-79; PMID:20383718; http://dx.doi.org/10.1007/s00424-010-0817-1
   PubMed Web of Science ®Google Scholar
• Wulff H, Köhler R. Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets. J Cardiovas Pharmacol 2013; 61:102-12; PMID:23107876; http://dx.doi.org/10.1097/FJC.0b013e318279ba20
   PubMed Web of Science ®Google Scholar
• Damkjaer M, Nielsen G, Bodendiek S, Staehr M, Gramsbergen JB, de Wit C, Jensen BL, Simonsen U, Bie P, Wulff H, et al. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs. Br J Pharmacol 2012; 165:223-34; PMID:21699504; http://dx.doi.org/10.1111/j.1476-5381.2011.01546.x
   PubMed Web of Science ®Google Scholar
• Radtke J, Schmidt K, Wulff H, Kohler R, de Wit C. Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice. Br J Pharmacol 2013; 170:293-303; PMID:23734697; http://dx.doi.org/10.1111/bph.12267
   PubMed Web of Science ®Google Scholar
• Toyama K, Wulff H, Chandy KG, Azam P, Raman G, Saito T, Fujiwara Y, Mattson DL, Das S, Melvin JE, et al. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest 2008; 118:3025-37; PMID:18688283; http://dx.doi.org/10.1172/JCI30836
   PubMed Web of Science ®Google Scholar
• Bi D, Toyama K, Lemaître V, Takai J, Fan F, Jenkins DP, Wulff H, Gutterman DD, Park F, Miura H. The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling. J Biol Chem 2013; 288:15843-53; PMID:23609438; http://dx.doi.org/10.1074/jbc.M112.427187
   PubMed Web of Science ®Google Scholar
• Lamy C, Goodchild SJ, Weatherall KL, Jane DE, Liégeois JF, Seutin V, Marrion NV. Allosteric block of KCa2 channels by apamin. J Biol Chem 2010; 285:27067-77; PMID:20562108; http://dx.doi.org/10.1074/jbc.M110.110072
   PubMed Web of Science ®Google Scholar
• Weatherall KL, Seutin V, Liegeois JF, Marrion NV. Crucial role of a shared extracellular loop in apamin sensitivity and maintenance of pore shape of small-conductance calcium-activated potassium (SK) channels. Proc Natl Acad Sci USA 2011; 108:18494-9; PMID:22025703; http://dx.doi.org/10.1073/pnas.1110724108
   PubMed Web of Science ®Google Scholar
• Strøbaek D1, Hougaard C, Johansen TH, Sørensen US, Nielsen EØ, Nielsen KS, Taylor RD, Pedarzani P, Christophersen P. Inhibitory gating modulation of small conductance Ca2+-activated K+ channels by the synthetic compound (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) reduces afterhyperpolarizing current in hippocampal CA1 neurons. Mol Pharmacol 2006; 70:1771-82; PMID:16926279; http://dx.doi.org/10.1124/mol.106.027110
   PubMed Web of Science ®Google Scholar
• Sørensen US1, Strøbaek D, Christophersen P, Hougaard C, Jensen ML, Nielsen EØ, Peters D, Teuber L. Synthesis and structure-activity relationship studies of 2-(N-substituted)-aminobenzimidazoles as potent negative gating modulators of small conductance Ca2+-activated K+ channels. J Med Chem 2008; 51:7625-34; PMID:18998663; http://dx.doi.org/10.1021/jm800809f
   PubMed Web of Science ®Google Scholar
• Campos Rosa J, Galanakis D, Piergentili A, Bhandari K, Ganellin CR, Dunn PM, Jenkinson DH. Synthesis, molecular modeling, and pharmacological testing of bis-quinolinium cyclophanes: potent, non-peptidic blockers of the apamin-sensitive Ca2+-activated K+ channel. J Med Chem 2000; 43:420-31; PMID:10669569; http://dx.doi.org/10.1021/jm9902537
   PubMed Web of Science ®Google Scholar
• Fletcher DI, Ganellin CR, Piergentili A, Dunn PM, Jenkinson DH. Synthesis and pharmacological testing of polyaminoquinolines as blockers of the apamin-sensitive Ca2+-activated K+ channel (SKCa). Bioorg Med Chem 2007; 15:5457-79; PMID:17560109; http://dx.doi.org/10.1016/j.bmc.2007.05.054
   PubMed Web of Science ®Google Scholar
• Oliván-Viguera A1, Valero MS, Murillo MD, Wulff H, García-Otín AL, Arbonés-Mainar JM, Köhler R. Novel phenolic inhibitors of small/intermediate-conductance Ca2+-activated K+ channels, KCa3.1 and KCa2.3. PLoS One 2013; 8:e58614; PMID:23516517; http://dx.doi.org/10.1371/journal.pone.0058614
   PubMedGoogle Scholar
• Oliván-Viguera A, Valero MS, Coleman N, Brown BM, Laría C, Murillo MD, Gálvez JA, Díaz-de-Villegas MD, Wulff H, Badorrey R, et al. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo. Mol Pharmacol 2015; 87:338-48; PMID:25468883; http://dx.doi.org/10.1124/mol.114.095745
   PubMed Web of Science ®Google Scholar
• Jenkins DP1, Strøbæk D, Hougaard C, Jensen ML, Hummel R, Sørensen US, Christophersen P, Wulff H. Negative gating modulation by (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) depends on residues in the inner pore vestibule: pharmacological evidence of deep-pore gating of K(Ca)2 channels. Mol Pharmacol 2011; 79:899-909; PMID:21363929; http://dx.doi.org/10.1124/mol.110.069807
   PubMed Web of Science ®Google Scholar
• Bruening-Wright A, Lee WS, Adelman JP, Maylie J. Evidence for a deep pore activation gate in small conductance Ca2+-activated K+ channels. J Gen Physiol 2007; 130:601-10; PMID:17998394; http://dx.doi.org/10.1085/jgp.200709828
   PubMed Web of Science ®Google Scholar
• Wulff H, Gutman GA, Cahalan MD, Chandy KG. Delineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1. J Biol Chem 2001; 276:32040-5; PMID:11425865; http://dx.doi.org/10.1074/jbc.M105231200
   PubMed Web of Science ®Google Scholar
• Herrik KF, Christophersen P, Shepard PD. Pharmacological modulation of the gating properties of small conductance Ca2+-activated K+ channels alters the firing pattern of dopamine neurons in vivo. J Neurophysiol 2010; 104:1726-35; PMID:20660424; http://dx.doi.org/10.1152/jn.01126.2009
   PubMed Web of Science ®Google Scholar
• Skibsbye L, Wang X, Axelsen LN, Bomholtz SH, Nielsen MS, Grunnet M, Bentzen BH, Jespersen T. Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat Atrium. J Cardiovasc Pharmacol 2015; PMID:25856531
   PubMed Web of Science ®Google Scholar
• Haugaard MM, Hesselkilde EZ, Pehrson S, Carstensen H, Flethøj M, Præstegaard KF, Sørensen US, Diness JG, Grunnet M, Buhl R, et al. Pharmacologic inhibition of small-conductance calcium-activated potassium (SK) channels by NS8593 reveals atrial antiarrhythmic potential in horses. Heart Rhythm 2015; 12:825-35; PMID:25542425; http://dx.doi.org/10.1016/j.hrthm.2014.12.028
   PubMed Web of Science ®Google Scholar
• Diness JG, Skibsbye L, Jespersen T, Bartels ED, Sørensen US, Hansen RS, Grunnet M. Effects on atrial fibrillation in aged hypertensive rats by Ca2+-activated K+ channel inhibition. Hypertension 2011; 57:1129-35; PMID:21502564; http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.170613
   PubMed Web of Science ®Google Scholar
• Jenkins DP, Yu W, Brown BM, Lojkner LD, Wulff H. Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activators. Assay Drug Dev Technol 2013; 11:551-60; PMID:24351043; http://dx.doi.org/10.1089/adt.2013.543
   PubMed Web of Science ®Google Scholar
• Korsgaard MP, Strøbæk D, Christophersen P. Automated planar electrode electrophysiology in drug discovery: examples of the use of QPatch in basic characterization and high content screening on Na(v), K(Ca)2.3, and K(v)11.1 channels. Comb Chem High Throughput Screen 2009; 12:51-63; PMID:19149491; http://dx.doi.org/10.2174/138620709787048037
   PubMed Web of Science ®Google Scholar
• Jorgensen S, Dyhring T, Brown DT, Strøbæk D, Christophersen P, Demnitz J. A high-throughput screening campaign for detection of Ca2+-activated K+ channel activators and inhibitors using a fluorometric imaging plate reader-based Tl+-influx assay. Assay Drug Dev Technol 2013; 11:163-72; PMID:23198866; http://dx.doi.org/10.1089/adt.2012.479
   PubMed Web of Science ®Google Scholar